Suppr超能文献

提取红细胞酶以制备多聚血红蛋白-过氧化氢酶-超氧化物歧化酶。

Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase.

作者信息

Gu Jingsong, Chang Thomas Ming Swi

机构信息

Artificial Cells & Organs Research Centre, Department of Physiology, McGill University, Montreal, Quebec, Canada.

出版信息

Artif Cells Blood Substit Immobil Biotechnol. 2009;37(2):69-77. doi: 10.1080/10731190902742240. Epub 2009 Feb 18.

Abstract

In sustained severe ischemia, reperfusion with oxygen carriers may result in ischemia-reperfusion injuries because of the release of damaging oxygen radicals. A nanobiotechnology-based polyhemogloin-calatase-superoxide dismutase can prevent this because the oxygen carrier, polyhemoglobin, is linked to antioxidant enzymes, catalase and superoxide dismutase. However, these antioxidant enzymes come from nonhuman sources and recombinant human enzymes are expensive. This paper describes our study on extracting these enzymes from red blood cells and analyzing the amount of enzymes needed for adequate protection from ischemia-reperfusion.

摘要

在持续性严重缺血的情况下,使用氧载体进行再灌注可能会因有害氧自由基的释放而导致缺血再灌注损伤。一种基于纳米生物技术的聚血红蛋白-过氧化氢酶-超氧化物歧化酶可以预防这种情况,因为氧载体聚血红蛋白与抗氧化酶过氧化氢酶和超氧化物歧化酶相连。然而,这些抗氧化酶来自非人类来源,且重组人源酶价格昂贵。本文描述了我们从红细胞中提取这些酶并分析充分保护免受缺血再灌注所需酶量的研究。

相似文献

1
Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase.
Artif Cells Blood Substit Immobil Biotechnol. 2009;37(2):69-77. doi: 10.1080/10731190902742240. Epub 2009 Feb 18.
7
Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
Nat Biotechnol. 1998 Jul;16(7):667-71. doi: 10.1038/nbt0798-667.
10
Early phase of reperfusion of human kidney allograft does not affect an erythrocyte anti-oxidative system.
Nephrology (Carlton). 2006 Oct;11(5):467-70. doi: 10.1111/j.1440-1797.2006.00672.x.

引用本文的文献

本文引用的文献

1
Nanobiotechnology for hemoglobin-based blood substitutes.
Crit Care Clin. 2009 Apr;25(2):373-82, Table of Contents. doi: 10.1016/j.ccc.2008.12.006.
2
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.
J Am Coll Surg. 2009 Jan;208(1):1-13. doi: 10.1016/j.jamcollsurg.2008.09.023. Epub 2008 Nov 7.
3
Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.
Biochim Biophys Acta. 2008 Oct;1784(10):1435-40. doi: 10.1016/j.bbapap.2008.05.006. Epub 2008 Jun 17.
4
First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
Expert Opin Biol Ther. 2007 May;7(5):665-75. doi: 10.1517/14712598.7.5.665.
5
The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable.
J Am Coll Surg. 2002 Oct;195(4):445-52; discussion 452-5. doi: 10.1016/s1072-7515(02)01335-2.
6
Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
Nat Biotechnol. 1998 Jul;16(7):667-71. doi: 10.1038/nbt0798-667.
8
Isolation and characterization of superoxide dismutase.
Methods Enzymol. 1984;105:88-93. doi: 10.1016/s0076-6879(84)05012-6.
10
Superoxide dismutase: improved assays and an assay applicable to acrylamide gels.
Anal Biochem. 1971 Nov;44(1):276-87. doi: 10.1016/0003-2697(71)90370-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验